https://www.selleckchem.com/products/cc-122.html
All measured trough concentrations were ≥0.7 mg/L and 11/16 were ≥1 mg/L, which are the haematological thresholds for prophylaxis and treatment of invasive aspergillosis, respectively. The targeted PTA (90%) was attained for prophylaxis but not for treatment. ECMO does not appear to influence posaconazole exposure compared with haematology patients. However, some trough levels were below the lower limit for treatment. An a priori dose adjustment does not appear to be necessary but drug monitoring is recommended. ECMO does not appear
Beğen
Yorum Yap
Paylaş
